Tilray Brands, Inc. (TLRY) has been a topic of intense discussion on Reddit forums, with users expressing frustration over the company's current strategy and financial performance. One user voiced concerns about the company's acquisitions, suggesting they might be inflating revenue figures without addressing underlying financial issues. The user called for more transparency, similar to Ford's approach, to clearly communicate which divisions are profitable. Another user echoed this sentiment, expressing a desire for the company to focus on profitability rather than expansion.
In another thread, users discussed strategies for managing their investments in Tilray, with some advocating for selling covered calls to generate extra cash while holding shares. One user mentioned selling calls when the stock was valued at $2.20 but noted that the current low valuation makes this strategy less appealing. The conversation also touched on the potential for future volatility and the hope that the stock price will rise above $3 by 2027, despite the current challenges.
The discussions also highlighted positive developments in Tilray's international operations, particularly in the UK, where medical cannabis sales are improving. A user noted that Tilray Porto is set to introduce up to 30 new strains in the UK, which could contribute to increased quarterly revenues. Despite these optimistic projections, the stock remains at a low point, with the current price holding steady at $1.30.